Harald Reinhart

Dr. Harald Reinhart is an Assistant Clinical Professor in the Department of Infectious Diseases at the Yale School of Medicine, Yale University. He specializes in clinical and translational research focusing on antimicrobial therapy, pharmacokinetics, and drug safety. His work spans infectious diseases, bacterial resistance mechanisms, and novel antibiotic formulations.

Education: MD from University of Würzburg (1978).

Research Focus: Dr. Reinhart’s research emphasizes optimizing antibiotic dosing regimens, evaluating drug efficacy against resistant pathogens, and developing safer antimicrobial treatments. Key areas include:

• Pharmacokinetic profiling of novel antibiotics (e.g., omadacycline, efgartigimod)
• Combating multidrug-resistant bacteria like Acinetobacter baumannii through beta-lactamase inhibitors
• Topical drug delivery for psoriasis and urinary tract infections

Publications Trends: His recent work (2020–2024) prioritizes:

• Chinese patient pharmacokinetic studies
• Comparative efficacy of sulbactam/durlobactam vs. colistin
• Novel formulations for enhanced antibiotic absorption

Labs/Teams: While specific lab affiliations are unspecified, his collaborations likely involve translational microbiology and pharmacology teams at Yale School of Medicine.